| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Angiogenesis inhibition plus chemotherapy for metastatic hormone refractory prostate cancer: History and rationale
|
Ryan, Charles J.
|
|
2006
|
24 |
3 |
p. 250-253
4 p.
|
artikel
|
| 2 |
Anti-angiogenic and cytotoxic targeted systemic therapy for high-risk prostate cancer
|
Rashid, Hani H.
|
|
2006
|
24 |
3 |
p. 243-245
3 p.
|
artikel
|
| 3 |
Antiprostasome antibodies: Possible serum markers for prostate cancer metastasizing liability
|
Larsson, Anders
|
|
2006
|
24 |
3 |
p. 195-200
6 p.
|
artikel
|
| 4 |
Cancer immunomics: Using autoantibody signatures in the early detection of prostate cancer
|
Bradford, Timothy J.
|
|
2006
|
24 |
3 |
p. 237-242
6 p.
|
artikel
|
| 5 |
Clinical symptoms in localized renal cell carcinoma reflect its invasive potential: Comparative study between incidentally detected and symptomatic diseases
|
Harada, Ken-ichi
|
|
2006
|
24 |
3 |
p. 201-206
6 p.
|
artikel
|
| 6 |
Complete long-term survival data from a trial of adjuvant chemotherapy vs control after radical cystectomy for locally advanced bladder cancer
|
See, William A.
|
|
2006
|
24 |
3 |
p. 275-276
2 p.
|
artikel
|
| 7 |
Contents
|
|
|
2006
|
24 |
3 |
p. vii-viii
nvt p.
|
artikel
|
| 8 |
Current status of anti-angiogenesis therapy for prostate cancer
|
Jiménez, Juan Antonio
|
|
2006
|
24 |
3 |
p. 260-268
9 p.
|
artikel
|
| 9 |
Editorial board
|
|
|
2006
|
24 |
3 |
p. iv-
1 p.
|
artikel
|
| 10 |
Fluorescence in situ hybridization for detecting transitional cell carcinoma: Implications for clinical practice
|
Grossman, H. Barton
|
|
2006
|
24 |
3 |
p. 270-271
2 p.
|
artikel
|
| 11 |
Gene expression profiling of noninvasive primary urothelial tumours using microarrays
|
Grossman, H. Barton
|
|
2006
|
24 |
3 |
p. 273-
1 p.
|
artikel
|
| 12 |
HYTAD1-p20: A new paclitaxel-hyaluronic acid hydrosoluble bioconjugate for treatment of superficial bladder cancer
|
Rosato, Antonio
|
|
2006
|
24 |
3 |
p. 207-215
9 p.
|
artikel
|
| 13 |
Information for Authors
|
|
|
2006
|
24 |
3 |
p. CO3-
1 p.
|
artikel
|
| 14 |
International comparisons of prostate cancer mortality rates with dietary practices and sunlight levels
|
Colli, Janet Laura
|
|
2006
|
24 |
3 |
p. 184-194
11 p.
|
artikel
|
| 15 |
Intravesical bacillus Calmette-Guérin therapy: Experience with a reduced dwell-time in patients with pronounced side-effects
|
See, William A.
|
|
2006
|
24 |
3 |
p. 276-
1 p.
|
artikel
|
| 16 |
Is adjuvant chemotherapy for bladder cancer safer in patients with an ileal conduit than a neobladder?
|
Grossman, H. Barton
|
|
2006
|
24 |
3 |
p. 272-
1 p.
|
artikel
|
| 17 |
Making prostate-specific antigen testing more effective
|
Catalona, William J.
|
|
2006
|
24 |
3 |
p. 177-179
3 p.
|
artikel
|
| 18 |
Masthead
|
|
|
2006
|
24 |
3 |
p. iii-
1 p.
|
artikel
|
| 19 |
NAT2 slow acetylation and bladder cancer in workers exposed to benzidine
|
See, William A.
|
|
2006
|
24 |
3 |
p. 273-
1 p.
|
artikel
|
| 20 |
Neoadjuvant mitoxantrone and docetaxel for high-risk localized prostate cancer
|
Garzotto, Mark
|
|
2006
|
24 |
3 |
p. 254-259
6 p.
|
artikel
|
| 21 |
Prostate adenocarcinoma manifesting as generalized lymphadenopathy
|
Moura, Fabiana M.
|
|
2006
|
24 |
3 |
p. 216-219
4 p.
|
artikel
|
| 22 |
Prostate cancer: Molecular approaches for detection and prognosis, and angiogenic therapeutic targets
|
Rashid, Hani H.
|
|
2006
|
24 |
3 |
p. 220-221
2 p.
|
artikel
|
| 23 |
Proteomics for the identification of new prostate cancer biomarkers
|
Ornstein, David K.
|
|
2006
|
24 |
3 |
p. 231-236
6 p.
|
artikel
|
| 24 |
Sequential BCG and electromotive mitomycin versus BCG alone for high-risk superficial bladder cancer: A randomised controlled trial
|
Grossman, H. Barton
|
|
2006
|
24 |
3 |
p. 271-272
2 p.
|
artikel
|
| 25 |
Single nucleotide polymorphisms: Early diagnosis and risk assessment in genitourinary malignancy
|
Kibel, Adam S.
|
|
2006
|
24 |
3 |
p. 224-230
7 p.
|
artikel
|
| 26 |
Surveillance for recurrent bladder cancer using a point-of-care proteomic assay
|
See, William A.
|
|
2006
|
24 |
3 |
p. 274-275
2 p.
|
artikel
|
| 27 |
Survey Section Editorial Board
|
|
|
2006
|
24 |
3 |
p. 269-
1 p.
|
artikel
|
| 28 |
The application of genomic and proteomic approaches to human prostate cancer in developing diagnostic and prognostic markers
|
Brooks, James D.
|
|
2006
|
24 |
3 |
p. 222-223
2 p.
|
artikel
|
| 29 |
The use of thalidomide in androgen-independent prostate cancer
|
Cox, Michael C.
|
|
2006
|
24 |
3 |
p. 246-249
4 p.
|
artikel
|
| 30 |
Treatment delay and prognosis in invasive bladder cancer
|
See, William A.
|
|
2006
|
24 |
3 |
p. 274-
1 p.
|
artikel
|
| 31 |
Treatment of stage I seminoma: A 15-year review
|
Alomary, Ibraheem
|
|
2006
|
24 |
3 |
p. 180-183
4 p.
|
artikel
|
| 32 |
Urothelial neoplasms in patients 20 years or younger: A clinicopathological analysis using the World Health Organization 2004 bladder consensus classification
|
Grossman, H. Barton
|
|
2006
|
24 |
3 |
p. 270-
1 p.
|
artikel
|
Tijdschrift beschrijving